pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Rare Disease · news · pharmadog
← back to Rare Disease
News mentioning Rare Disease
497
stories
20d
Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck
biospace
20d
New biotech Setara forms with $90M to take on Jazz’s bonus rare disease programs
biospace
20d
Setara gets $90M to continue rare disease pipeline spun out of Jazz's Actio deal
endpoints
21d
Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms
biospace
22d
FDA unveils guidance for ‘plug and play’ gene therapies
biopharma dive
22d
STAT+: Senate candidate El-Sayed wants to ‘grill’ RFK Jr., calls him the ‘most incompetent HHS secretary ever’
stat
22d
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
biospace
22d
FDA’s rare disease framework aims to ‘stand the test of time’
fiercebiotech
22d
STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more
stat
22d
Data leak kickstarts ESMO, BMS reports autoimmune CAR T death, pharma M&A outpaces 2025
biospace
22d
Biogen CEO tells analysts he’s focused on early-stage R&D as ‘we were not very good with that’
fiercebiotech
22d
Big Pharma is ready to strike, with J&J most likely to buy: Leerink
biospace
23d
STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies
stat
23d
STAT+: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own
stat
24d
FDA issues draft guidance on individualized gene editing products to fill ‘critical gap’
raps
24d
ESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancer
biospace
25d
Diamantas touts new rare disease framework, greater emphasis on patient voice
raps
27d
STAT+: Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds
stat
27d
BMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trial
biospace
27d
STAT+: Up and down the ladder: The latest comings and goings
stat
27d
ESMO 2026: Tango trips on sinking response rates in pancreatic cancer but will move to Phase 3
biospace
27d
STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more
stat
27d
STAT+: Alnylam says Huntington’s drug shows promise in early study
stat
28d
STAT+: Gilead to pay $45 million to settle kickback charges filed by Texas attorney general
stat
28d
Biohaven’s previously rejected rare disease drug to get fresh FDA review
biopharma dive
28d
Looking Beyond the First Answer Towards Delivering Impact
fiercebiotech
28d
Biohaven shares pop as FDA accepts resubmission for ataxia drug with adcomm expected
biospace
28d
STAT+: Crackdowns loom, from China to New York
stat
28d
STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more
stat
28d
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
stat
← prev
page 3 of 17
next →